A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus

Archives of Virology

Volumn 159, Issue 10, 2014, Pages 2651-2658

  Cheresiz, S V ^a,b,c   Kononova, A A ^a   Razumova, Yu V ^a   Dubich, T S ^a   Chepurnov, A A ^d   Kushch, A A ^e   Davey, R ^f   Pokrovsky, A G ^a,b  

^a NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

^b INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^c INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^d INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

^e D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^f SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; OSELTAMIVIR; SIALIDASE; VIRUS ANTIBODY;

ANALOGS AND DERIVATIVES; BIOSYNTHESIS; CHIMERA; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; METABOLISM; PATHOGENICITY; PATHOLOGY; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS; VIROLOGY;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHIMERA; HEK293 CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; NEURAMINIDASE; OSELTAMIVIR; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS;

EID: 84907688058     PISSN: 03048608     EISSN: 14328798     Source Type: Journal    
DOI: 10.1007/s00705-014-2127-y     Document Type: Article

References (20)

1. Su CY, Wang SY, Shie JJ, Jeng KS, Temperton NJ, Fang JM, Wang CH, Cheng YS (2008) In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses. Antiviral Res 79(3):199–205. doi:10.1016/j.antiviral.2008.03.002
2. Su Y, Zhu X, Wang Y, Wu M, Tien P (2008) Evaluation of Glu11 and Gly8 of the H5N1 influenza hemagglutinin fusion peptide in membrane fusion using pseudotype virus and reverse genetics. Arch Virol 153:247–257. doi:10.1007/s00705-007-1088-9
3. Wang SY, Su CY, Lin M, Huang SY, Huang WI, Wang CC, Wu YT, Cheng TJ, Yu HM, Ren CT, Wu CY, Wang CH, Cheng YS (2009) HA-pseudotyped retroviral vectors for influenza antagonist screening. J Biomol Screen 14:294–302. doi:10.1177/1087057108330786
4. Wang W, Butler EN, Veguilla V, Vassell R, Thomas JT, Moos M Jr, Ye Z (2008) Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J Virol Methods 153:111–119. doi:10.1016/j.jviromet.2008.07.015
5. Zhang F, Wu J, Xu C, Lin X, Zhao H, Lu J, Zhang Y, Lu J, Zhang X, Ma J, Shu Y, Lou Y, Gao J, Wang Y (2011) Infectivity of pseudotyped particles pairing hemagglutinin of highly pathogenic avian influenza a H5N1 virus with neuraminidases of the 2009 pandemic H1N1 and a seasonal H3N2. J Bioterr Biodef 2(1):1–6. doi:10.4172/2157-2526.1000104
6. Ogino M, Ebihara H, Lee BH, Araki K, Lundkvist A, Kawaoka Y, Yoshimatsu K, Arikawa J (2003) Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin Diagn Lab Immunol 10:154–160. doi:10.1128/CDLI.10.1.154-160.2003
7. Fukushi S, Tani H, Yoshikawa T, Sajio M, Morikawa S (2012) Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers. Viruses 4(10):2097–2114. doi:10.3390/v4102097
8. Fukushi S, Mizutani T, Saijo M, Matsuyama S, Miyajima N, Taguchi F, Itamura S, Kurane I, Morikawa S (2005) Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol 86:2269–2274. doi:10.1099/vir.0.80955-0
9. Moore MJ, Dorfman T, Li W, Wong SK, Li Y, Kuhn JH, Coderre J, Vasilieva N, Han Z, Greenough TC, Farzan M, Choe H (2004) Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. J Virol 78:10628–10635. doi:10.1128/JVI.78.19.10628-10635.2004
10. Kushch AA, Klimova RR, Masalova OV, Fedorova NE, Botikov AG, Fedyakina IT, Burtseva EI, Isaeva EI, Deryabin PG, L`vov DK (2008) Production and properties of monoclonal antibodies to a highly pathogenic strain of avian influenza virus A(H5N1) isolated in Russia. Vopr Virusol 53(5):9–14 (in Russian)
11. Roth MG, Compans RW (1981) Delayed appearance of pseudotypes between vesicular stomatitis virus and influenza virus during mixed infection of MDCK cells. J Virol 40(3):848–860
12. Kretzschmar E, Buonocore L, Schnell MJ, Rose JK (1997) High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J Virol 71(8):5982–5989
13. Kalhoro NH, Veits J, Rautenschlein S, Zimmer G (2009) A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1). Vaccine 27(8):1174–1183
14. Hanika A, Larisch B, Steinmann E, Schwegmann-Weßels C, Herrler G, Zimmer G (2005) Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes. J Gen Virol 86:1455–1465
15. Wang W, Xie H, Ye Z, Vassell R, Weiss CD (2010) Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays. J Virol Methods 165(2):305–310. doi:10.1016/j.jviromet.2010.02.009
16. Wang W, Castelán-Vega JA, Jiménez-Alberto A, Vassell R, Ye Z, Weiss CD (2010) A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity. Virology 407(2):374–380. doi:10.1016/j.virol.2010.08.027
17. Nefkens I, Garcia J-M, Ling CS, Lagarde N, Nicholls J, Tang DJ, Peiris M, Buchy P, Altmeyer R (2007) Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J Clin Virol 39:27–33. doi:10.1016/j.jcv.2007.02.005
18. Tisoncik-Go J, Cordero KS, Rong L (2013) Analysis of oseltamivir resistance substitutions in influenza virus glycoprotein neuraminidase using a lentivirus-based surrogate assay system. Virol Sin 28(2):081–091
19. Talekar A, Pessi A, Glickman F, Sengupta U, Briese T, Whitt MA, Mathieu C, Horvat B, Moscona A, Porotto M (2012) Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment. PLoS ONE 7(3):e30538. doi:10.1371/journal.pone.0030538
20. Matrosovich M, Herrler G, Klenk HD (2013) Sialic acid receptors of viruses. Top Curr Chem. [Epub ahead of print]. doi: 10.1007/128_2013_466